Nyxoah's ACCCESS Trial Of Genio System Meets Primary Goals In CCC Sleep Apnea Patients; Shares Jump

Nyxoah SA reported positive data from its ACCCESS U.S. pivotal study evaluating the Genio system in adults with moderate-to-severe Obstructive Sleep Apnea (OSA) and Complete Concentric Collapse (CCC). While no effect sizes or endpoints were provided in the excerpt, the update is a constructive regulatory/clinical milestone for the company’s lead technology. The news should be supportive for sentiment around NYXH as it advances toward potential further clinical and approval steps.